Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|August 15, 2017
3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccineQian Wang, Meagan A Barry, Christopher A Seid, et al.Nature Communications|June 30, 2019
Co-emergence of magnetic order and structural fluctuations in magnetiteGiuditta Perversi, Elise Pachoud, James Cumby, et al.Scientific Reports|August 12, 2017
Crystal Structure of MpPR-1i, a SCP/TAPS protein from Moniliophthora perniciosa, the fungus that causes Witches' Broom Disease of CacaoRenata M Baroni, Zhipu Luo, Rabih Darwiche, et al.Scientific Reports|November 12, 2017
Crystal Structure of Borrelia turicatae protein, BTA121, a differentially regulated gene in the tick-mammalian transmission cycle of relapsing fever spirochetesZhipu Luo, Alan J Kelleher, Rabih Darwiche, et al.The Review of Scientific Instruments|March 8, 2013
High speed synchrotron x-ray phase contrast imaging of dynamic material response to split Hopkinson bar loadingM Hudspeth, B Claus, S Dubelman, et al.Journal of Pharmaceutical Sciences|December 25, 2017
Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas DiseaseAmadeo B Biter, Sarah Weltje, Elissa M Hudspeth, et al.Journal of Pharmaceutical Sciences|May 1, 2017
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine CandidateWen-Hsiang Chen, Shivali M Chag, Mohan V Poongavanam, et al.Human Vaccines & Immunotherapeutics|December 21, 2013
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidateWen-Hsiang Chen, Lanying Du, Shivali M Chag, et al.Vaccine|July 21, 2015
Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in miceViridiana Martinez-Campos, Pedro Martinez-Vega, Maria Jesus Ramirez-Sierra, et al.Human Vaccines & Immunotherapeutics|February 4, 2016
Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic propertiesElissa M Hudspeth, Qian Wang, Christopher A Seid, et al.Pageof 3